News
BOEUF
32.50
NaN%
--
BONESUPPORT Repurchases 25,000 Shares Under Buyback Program
TipRanks · 5d ago
BONESUPPORT Continues Share Buy-Back to Optimize Capital Structure
TipRanks · 10/26 13:32
BONESUPPORT AB Earnings Call Signals Robust Growth
TipRanks · 10/26 00:17
BONESUPPORT Posts Strong Q3 Growth as Reimbursement and Clinical Data Bolster Strategy
TipRanks · 10/22 06:36
BONESUPPORT schedules Q3 2026 report and investor webcast
TipRanks · 10/16 07:00
BONESUPPORT Advances SEK 100m Share Buy-Back to Adjust Capital Structure
TipRanks · 10/12 13:33
BONESUPPORT Expands Share Buy-Back as Treasury Holdings Grow
TipRanks · 09/28 13:35
BONESUPPORT Builds Momentum for CERAMENT as U.S. Reimbursement and Clinical Data Align
TipRanks · 09/21 14:32
BONESUPPORT Expands Share Buy-Back to Strengthen Capital Structure
TipRanks · 09/21 13:32
BONESUPPORT Submits Full Data Package for CERAMENT V De Novo to FDA
TipRanks · 09/21 06:32
BONESUPPORT’s SOLARIO Study in NEJM Backs Shorter Antibiotic Courses for Bone Infections
TipRanks · 09/17 08:02
BONESUPPORT Taps Stryker for Australia and New Zealand Expansion
TipRanks · 09/11 13:03
BONESUPPORT Launches SEK 100m Share Buy-Back to Optimize Capital Structure
TipRanks · 09/07 13:32
BONESUPPORT Launches SEK 100 Million Share Buy-Back to Adjust Capital Structure
TipRanks · 09/01 11:33
BONESUPPORT Faces FDA Timeline Extension for CERAMENT V De Novo Submission
TipRanks · 08/27 06:33
CMS Grants Higher U.S. Reimbursement for BONESUPPORT’s CERAMENT G
TipRanks · 08/03 06:44
Bonesupport Holding AB Delivers High-Growth Earnings Call
TipRanks · 07/17 00:06
Bonesupport Holding AB (publ) GAAP EPS of SEK 1.23, revenue of SEK 355.7M
Seeking Alpha · 07/16 12:34
Bonesupport lifts earnings on strong Q2 sales as Medicare proposal boosts outlook
TipRanks · 07/16 06:36
BONESUPPORT schedules Q2 2026 results webcast and call
TipRanks · 07/09 06:33
More
Webull provides a variety of real-time BOEUF stock news. You can receive the latest news about Bonesupport Hldn through multiple platforms. This information may help you make smarter investment decisions.
About BOEUF
Bonesupport Holding AB is a Sweden-based orthobiologics company. It develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.